摘要
回顾性分析我院2000-07-2005-07经肝门胆管癌手术治疗的62例患者临床资料和随访结果,总结肝门胆管癌的手术治疗体会。62例手术切除患者中行根治性切除(R0)22例,非根治性切除28例(R1,R2)。根治性切除中位生存期34个月,1、3和5年生存率分别为92.0%、40.0%和18.0%;非根治性切除中位生存期16个月,1、3和5生存率分别为83.0%、22.0%和0。另12例未完成病灶切除,9例行经肿瘤切开放置Y管内支架引流,3例行胆囊桥式肝管一十二指肠吻合,中位生存期10个月,1、3和5年生存率分别为15.0%、0和0。手术切除是治疗肝门胆管癌的有效治疗方法,根治性切除能明显改善预后。
To summarize the experience in surgical resection for hepatic hilar Cholangiocarcinoma.The clinical and follow-up data of 62 patients with hepatic hilar cholangiocarcinoma receiving surgical resection in our hospital between July 2000 and July 2005 the 5 year were retrospectively analyzed.Of the 62 patients,22 underwent radical resection and 28 palliative resection.In the radical resection group.the median survival time was 34 months and the 1,3 and 5 year survival rates were 92.0%,40.0% and 18.0% ,In the palliative resection group,the median survival time was 16 months and the 1,3 and 5 year survival rates were 83.0%,22.0% and 0 ,other 12 cases of incomplete resection group,endoprosthesis drainage through Y tube was used in 9 patients and galibladder bridge hepatoduodenostomy was performed on 3 patients,the median survival time was 10 months and the 1,3 and 5 year survival rates were 15.0%,0 and 0.Surgical resection is the most efective method for treatment of hepatic hilar cholangiocarcinoma,the radical resection,might improve the prognosis of the patients with hilar cholangiocarcinoma.
出处
《中华肿瘤防治杂志》
CAS
2010年第20期1681-1682,共2页
Chinese Journal of Cancer Prevention and Treatment
关键词
胆管肿瘤/外科学
回顾性研究
随访研究
bile duct neoplasms/surgery
retrospective studies
follow studies